Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 200,000 shares at $39.41 ($7.9M) on 2026-07-01, disclosed to the SEC on 2026-07-02.
Open-market sale of $7.9M EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.41 | 130,352 | $5.1M | 65.2% |
| 2 | $39.41 | 69,648 | $2.7M | 34.8% |
| Total | $39.41 avg | 200,000 | $7.9M | 100% |
| Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |
| EWTX | SELL | 2025-05-07 | $26K | — | Filing → |